Citation: A. Parker et V. Parker, WHAT WE HAVE NOT LEARNED FROM THE TROUBLES WITH THE HUBBLE, IEEE aerospace and electronic systems magazine, 13(7), 1998, pp. 3-5
Citation: V. Parker, GREEK CRETE - STUDIES ON ITS STATE AND SO CIAL-DEVELOPMENT FROM THE 6TH-CENTURY-BC TO THE 4TH-CENTURY-AD - GERMAN - LINK,S, Gnomon, 70(1), 1998, pp. 43-47
Authors:
BENDELE A
SENNELLO G
MCABEE T
FRAZIER J
CHLIPALA E
PARKER V
Citation: A. Bendele et al., SUSTAINED BLOOD-LEVELS OF INTERLEUKIN-1 RECEPTOR ANTAGONIST IMPROVE EFFICACY IN ANIMAL-MODELS OF ARTHRITIS - COMPARISON TO HUMAN CLINICAL-DATA, Arthritis and rheumatism, 40(9), 1997, pp. 900-900
Authors:
FRUNCILLO R
TROY S
PARKER V
MAYERSOHN M
HICKS D
KRAML M
BATTLE M
CHIANG S
Citation: R. Fruncillo et al., PHARMACOKINETICS OF THE ALDOSE REDUCTASE INHIBITOR TOLRESTAT - STUDIES IN HEALTHY-YOUNG AND ELDERLY MALE AND FEMALE SUBJECTS AND IN SUBJECTS WITH DIABETES, Clinical pharmacology and therapeutics, 59(6), 1996, pp. 603-612
Authors:
HORAN T
WEN J
NARHI L
PARKER V
GARCIA A
ARAKAWA T
PHILO J
Citation: T. Horan et al., DIMERIZATION OF THE EXTRACELLULAR DOMAIN OF GRANULOCYTE-COLONY-STIMULATING FACTOR-RECEPTOR BY LIGAND-BINDING - A MONOVALENT LIGAND INDUCES 2 2 COMPLEXES/, Biochemistry, 35(15), 1996, pp. 4886-4896
Authors:
MENG X
PARKER V
BURGHART P
DILEA C
MALLETT S
GONEN B
CHIANG S
Citation: X. Meng et al., EFFECTS OF TOLRESTAT (T) ON PLASMA-GLUCOSE (G) LEVELS IN DIET-CONTROLLED, GLYBURIDE-CONTROLLED AND INSULIN-CONTROLLED (D, GLY AND I) DIABETICS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 154-154
Authors:
HUNT P
LI YS
NICHOL JL
HOKOM MM
BOGENBERGER JM
SWIFT SE
SKRINE JD
HORNKOHL AC
LU H
CLOGSTON C
MEREWETHER LA
JOHNSON MJ
PARKER V
KNUDTEN A
FARESE A
HSU RY
GARCIA A
STEAD R
BOSSELMAN RA
BARTLEY TD
Citation: P. Hunt et al., PURIFICATION AND BIOLOGIC CHARACTERIZATION OF PLASMA-DERIVED MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR, Blood, 86(2), 1995, pp. 540-547
Authors:
TURNER AM
BENNETT LG
LIN NL
WYPYCH J
BARTLEY TD
HUNT RW
ATKINS HL
LANGLEY KE
PARKER V
MARTIN F
BROUDY VC
Citation: Am. Turner et al., IDENTIFICATION AND CHARACTERIZATION OF A SOLUBLE C-KIT RECEPTOR PRODUCED BY HUMAN HEMATOPOIETIC-CELL LINES, Blood, 85(8), 1995, pp. 2052-2058
Authors:
HUNT P
BARTLEY T
LI YS
BOGENBERGER J
LU H
SAMAL B
MARTIN F
CHANG MS
PARKER V
BOSSELMAN B
Citation: P. Hunt et al., PURIFICATION AND CLONING OF A MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR - A NOVEL CYTOKINE FOUND IN APLASTIC PLASMA, Experimental hematology, 22(8), 1994, pp. 838-838
Authors:
MENG X
PARKER V
TURNER M
HICKS D
BOXENBAUM H
CHIANG S
Citation: X. Meng et al., EFFECT OF TOLRESTAT (T) ON PHARMACOKINETICS (PK) AND PHARMACODYNAMICSOF WARFARIN (W), Clinical pharmacology and therapeutics, 55(2), 1994, pp. 200-200
Authors:
LI YS
HUNT P
BOGENBERGER J
NICHOL J
KNUDTEN A
SKRINE J
MEREWETHER L
CLOGSTON C
SWIFT S
PARKER V
BOSSELMAN R
LU H
BARTLEY T
Citation: Ys. Li et al., PURIFICATION OF A MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR FROM APLASTIC CANINE AND PORCINE PLASMA, Blood, 84(10), 1994, pp. 10000330-10000330
Authors:
ELLIOTT S
BARTLEY T
DELORME E
DERBY P
HUNT R
LORENZINI T
PARKER V
ROHDE MF
STONEY K
Citation: S. Elliott et al., STRUCTURAL REQUIREMENTS FOR ADDITION OF O-LINKED CARBOHYDRATE TO RECOMBINANT ERYTHROPOIETIN, Biochemistry, 33(37), 1994, pp. 11237-11245